Literature DB >> 1700129

Comparison of SIV/SMM replication in CD4+ T cell and monocyte/macrophage cultures from rhesus macaques and sooty mangabeys.

T Yehuda-Cohen1, J D Powell, F Villinger, H M McClure, K W Sell, A Ahmed-Ansari.   

Abstract

Monocytes from SIV/SMM infected sooty mangabeys and rhesus macaques were incubated in vitro with live SIV/SMM. The reverse transcriptase (RT) activity in the supernatant fluids of the monocyte cultures of the former species was higher than the RT activity in the latter species. No differences were found in the supernatant fluid of similar cultures of CD4+ T cells from both these species. Autologous (but not allogeneic) CD8+ T cells from SIV infected mangabeys and rhesus macaques inhibited SIV replication in vitro. The suppression appeared more marked in monocytes from the mangabey species. These in vitro differences may relate to the clinically asymptomatic state of the sooty mangabeys and the disease-susceptible state of the rhesus macaques.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700129

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  3 in total

1.  Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease.

Authors:  M A Rey-Cuillé; J L Berthier; M C Bomsel-Demontoy; Y Chaduc; L Montagnier; A G Hovanessian; L A Chakrabarti
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection.

Authors:  L A Chakrabarti; S R Lewin; L Zhang; A Gettie; A Luckay; L N Martin; E Skulsky; D D Ho; C Cheng-Mayer; P A Marx
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.

Authors:  A Kaur; R M Grant; R E Means; H McClure; M Feinberg; R P Johnson
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.